Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SanBio completes enrollment in stem cell SB-623 trial

Sep. 5, 2013

Addex Therapeutics reports additional preclinical data on dipraglurant

Sep. 5, 2013

Parkinson's UK provides grant to study PBT-434

Sep. 5, 2013

Researchers at Amgen design novel Na(v)1.7 channel blockers

Sep. 5, 2013

Elan begins phase IIa study of ELND-005 for Down syndrome

Sep. 4, 2013

Zalicus completes patient enrollment in two phase II studies of Z-160

Sep. 4, 2013

Santhera Pharmaceuticals agrees with Takeda to license back European rights to Catena

Sep. 4, 2013

Extract from Calendula officinalis flowers improves memory, learning and attention in rodents

Sep. 4, 2013

InVivo Therapeutics outlines development plan for spinal cord injury program

Sep. 3, 2013

Benefit seen with ATX-MS-1467 in phase I multiple sclerosis trial

Sep. 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...